DexCom (DXCM)
(Delayed Data from NSDQ)
$69.00 USD
-0.70 (-1.00%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $68.91 -0.09 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$69.00 USD
-0.70 (-1.00%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $68.91 -0.09 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Zacks News
DexCom (DXCM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
DexCom (DXCM) closed the most recent trading day at $113.72, moving +0.49% from the previous trading session.
DexCom (DXCM) Stock Moves -0.59%: What You Should Know
by Zacks Equity Research
In the latest trading session, DexCom (DXCM) closed at $112.08, marking a -0.59% move from the previous day.
5 Stocks That Powered Nasdaq ETF Last Week
by Sweta Killa
The tech-heavy Nasdaq Composite Index outperformed last week, gaining 2.6%, while the S&P 500 and the Dow Jones were up 1.9% and 1.7%, respectively.
DexCom (DXCM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
DexCom (DXCM) closed the most recent trading day at $122.92, moving +1.39% from the previous trading session.
Universal Health (UHS) Q4 Earnings Beat on Solid Segments
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results indicate growing revenues in its segments resulting from higher patient volumes. Management expects adjusted EPS within $9.50-$10.50 for 2023.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Community Health (CYH) Q4 Earnings Beat on Strong Admissions
by Zacks Equity Research
Community Health's (CYH) fourth-quarter results indicate growing patient volumes. However, management estimates net loss per share to lie between 65 cents and 5 cents in 2023.
DexCom (DXCM) Q4 Earnings Beat Estimates, Volumes Remain Strong
by Zacks Equity Research
DexCom's (DXCM) fourth-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
DexCom (DXCM) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
DexCom (DXCM) delivered earnings and revenue surprises of 30.77% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
DexCom (DXCM) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
DexCom's (DXCM) fourth-quarter results are likely to reflect rising global awareness of its real-time CGM.
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
DexCom (DXCM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
DexCom (DXCM) closed the most recent trading day at $108.03, moving +0.3% from the previous trading session.
Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWP
DexCom (DXCM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
DexCom (DXCM) closed the most recent trading day at $106.72, moving +0.07% from the previous trading session.
Masimo's (MASI) Patient Monitoring Devices Favored by New Study
by Zacks Equity Research
Masimo's (MASI) patient monitoring devices continue to aid researchers in their assessment of different ventilatory strategies for brain oxygenation during thoracoscopic surgery.
DexCom (DXCM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
DexCom (DXCM) closed the most recent trading day at $107.86, moving +1.56% from the previous trading session.
Should Vanguard MidCap Growth ETF (VOT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOT
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
DexCom (DXCM) closed at $107.14 in the latest trading session, marking a +0.92% move from the prior day.
DexCom (DXCM) Announces Solid Preliminary Q4 Revenues
by Zacks Equity Research
DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its CGM sales.
3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised)
by Zacks Equity Research
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
DexCom (DXCM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, DexCom (DXCM) closed at $113.24, marking a +1.04% move from the previous day.
DexCom (DXCM) Stock Moves -0.1%: What You Should Know
by Zacks Equity Research
DexCom (DXCM) closed at $109.77 in the latest trading session, marking a -0.1% move from the prior day.
DexCom (DXCM) Stock Moves -0.94%: What You Should Know
by Zacks Equity Research
DexCom (DXCM) closed the most recent trading day at $113.68, moving -0.94% from the previous trading session.